IGF1 and bronchopulmonary dysplasia: There are new therapies under investigation at preclinical or early clinical stages that could be promising to reduce BPD: stem cell therapy, insulin like growth factor 1 (IGF-1) [35, 37, 46], and recombinant human surfactant protein D (rhSP-D) [47].